Computational Biology Startup Camp4 Therapeutics Launches With $30M in Series A Funding
NEW YORK (GenomeWeb) – Computational biology startup Camp4 Therapeutics has emerged from stealth mode and closed on a $30 million Series A round of venture capital.
Andreessen Horowitz led the round, with participation from Polaris Partners and the Kraft Group. Polaris Partners supported an earlier seed round, according to Cambridge, Massachusetts-based Camp4.